Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Argus Health
Baxter
Fish and Richardson
Healthtrust
Citi
Teva
Merck
Queensland Health

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for Patent: RE37950

« Back to Dashboard

Summary for Patent: RE37950
Title: Biogradable in-situ forming implants and methods of producing the same
Abstract:A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a non-reactive polymer in biocompatible solvent to form a liquid, placing the liquid within the animal, and allowing the solvent to dissipate to produce the implant. An alternative, thermosetting system comprises mixing together effective amounts of a liquid acrylic ester terminated, biodegradable prepolymer and a curing agent, placing the liquid mixture within an animal and allowing the prepolymer to cure to form the implant. Both systems provide a syringeable, solid biodegradable delivery system by the addition of an effective level of biologically active agent to the liquid before injection into the body.
Inventor(s): Dunn; Richard L. (Fort Collins, CO), English; James P. (Chelsea, AL), Cowsar; Donald R. (Savannah, GA), Vanderbilt; David P. (St. Louis, MO)
Assignee: Atrix Laboratories (Fort Collins, CO)
Application Number:09/536,579
Patent Claim Types:
see list of patent claims
Use; Composition; Device; Formulation; Delivery; Compound;

Drugs Protected by US Patent RE37950

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent RE37950

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 151257 ➤ Try a Free Trial
Austria 162398 ➤ Try a Free Trial
Austria 228861 ➤ Try a Free Trial
Australia 2605592 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
Chubb
Teva
McKesson
Merck
UBS
Chinese Patent Office
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.